Brief: Ocumension Therapeutics Sees Revenue RMB408 To RMB420 Million For Year
12/02/2025 15:52
Feb 12 (Reuters) - Ocumension Therapeutics 1477.HK :
* SEES REVENUE RMB408 MILLION TO RMB420 MILLION FOR YEAR
* EXPECTED RESULT DUE TO SIGNIFICANT INCREASE IN REVENUE
FROM
SALES OF OTHER OPHTHALMIC PHARMACEUTICAL PRODUCTS, OTHERS
Further company coverage: 1477.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application